Quoin Pharmaceuticals Ltd
QNRX
Company Profile
Business description
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
Contact
42127 Pleasant Forest Court
AshburnVA20148-7349
USAT: +1 703 980-4182
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
6
Stocks News & Analysis
stocks
6 undervalued US shares that crushed earnings
Atlassian and CarMax remain among the cheapest Morningstar-covered stocks after strong earnings beats.
stocks
Undervalued REIT offers attractive yield post earnings
Resilient income, attractive yield for Aussie REIT.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,274.20 | 5.60 | 0.06% |
| CAC 40 | 8,509.36 | 70.24 | -0.82% |
| DAX 40 | 26,128.36 | 210.25 | -0.80% |
| Dow JONES (US) | 53,389.62 | 70.16 | -0.13% |
| FTSE 100 | 10,728.04 | 7.74 | 0.07% |
| HKSE | 25,471.15 | 17.92 | 0.07% |
| NASDAQ | 26,383.29 | 261.62 | -0.98% |
| Nikkei 225 | 67,460.73 | 1,759.52 | -2.54% |
| NZX 50 Index | 13,866.18 | 144.20 | 1.05% |
| S&P 500 | 7,708.10 | 36.96 | -0.48% |
| S&P/ASX 200 | 9,070.00 | 5.20 | 0.06% |
| SSE Composite Index | 3,990.30 | 7.65 | 0.19% |